Tata Consultancy Services Ltd.

Tata Consultancy Services (TCS) has been named as Leader in the IDC MarketScape for Worldwide Life Science R&D Strategic Consulting Services. The report highlights that, TCS is fortifying its capabilities in the med-tech space, and its business transformation capabilities, providing an end-to-end automated, agile, and Intelligent Business 4.0 framework; end-to-end business operations ownership; value-based consulting; and a cross-business CXO-level focus.

It goes on to say TCS has been recognized for the strategic direction that it brings to its large clinical transformation programs, providing advisory services for regulatory and clinical IT landscape transformation, R&D business capabilities mapping, R&D long-range planning, and portfolio simplification and its expertise in everything related to data.

Using its Business 4.0 thought leadership framework, deep industry expertise, and intellectual property, TCS' life sciences consultants work collaboratively with customers and harness collective knowledge to draw up transformation roadmaps and design technology-led solutions with measurable impact in areas such as patient centricity, accelerated drug discovery, and clinical development. The company has also invested heavily in research and innovation capabilities in the life sciences domain. Its genomics labs offer capabilities such as DNA sequencing, marker validation, and translational research.

TCS is an IT services, consulting and business solutions organization that has been partnering with many of the world’s largest businesses in their transformation journeys for over 50 years.